Physician profile
Shari E Samson
NPI 1548277064
$1,320.54
in general payments reported to CMS, 2019-2025
11 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $108 · 2021: $275 · 2022: $15.07 · 2024: $488 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $361.19 | 2021-2025 | Impella |
| Chiesi USA, INC. | $164.57 | 2019-2024 | Cleviprex |
| Eagle Pharmaceuticals, INC. | $142.90 | 2024 | |
| La Jolla Pharmaceutical Company | $125.78 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $122.86 | 2020-2024 | Exparel |
| Heron Therapeutics, INC. | $122.10 | 2024 | Aponvie, Zynrelef |
| Merck Sharp & Dohme LLC | $106.25 | 2019-2025 | Bridion |
| Becton, Dickinson and Company | $62.62 | 2025 | |
| Medtronic, INC. | $44.13 | 2021 | |
| Edwards Lifesciences Corporation | $37.09 | 2025 | Pascal |
| Abbott Laboratories | $31.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Samson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.